Drug profile · INN
arsenic trioxide
ARSENIC TRIOXIDE ACCORD
arsenic trioxide (ARSENIC TRIOXIDE ACCORD) is a thioredoxin reductase 1 inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — arsenic trioxide
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
arsenic trioxide (ARSENIC TRIOXIDE ACCORD) is a thioredoxin reductase 1 inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thioredoxin reductase 1 inhibitor
Primary target: Thioredoxin reductase 1, cytoplasmic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is arsenic trioxide?
arsenic trioxide (ARSENIC TRIOXIDE ACCORD) is a thioredoxin reductase 1 inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for arsenic trioxide?
ARSENIC TRIOXIDE ACCORD is a marketed brand name for arsenic trioxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of arsenic trioxide?
arsenic trioxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.